In addition, the final outcome of a study [96] involves the identification of state and trait markers in the peripheral immune system and two immune-associated neuroendocrine pathways (IDO and GTP-CH1 pathways) in a longitudinal sample of psychosis patients [RQ1][RQ3][RQ4]. The gene discussed is IDO1; the disease is psychotic disorder.